Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1995 Dec;39(12):2610–2614. doi: 10.1128/aac.39.12.2610

Demonstration of synergy with fluconazole and either ibuprofen, sodium salicylate, or propylparaben against Candida albicans in vitro.

E M Scott 1, V N Tariq 1, R M McCrory 1
PMCID: PMC162998  PMID: 8592988

Abstract

The combination of fluconazole with either ibuprofen, sodium salicylate, or propylparaben resulted in synergistic activity (fractional inhibitory index, < 0.5) against Candida albicans NCYC 620 in a microdilution checkerboard assay. Synergism between miconazole and ibuprofen was also demonstrated. In three or four clinical isolates of C. albicans from AIDS patients, the combination of fluconazole and ibuprofen was synergistic. Preparation of the inoculum and the growth conditions used were those recommended by the National Committee for Clinical Laboratory Standards for susceptibility testing. A visual estimation of total inhibition of growth and determination of an 80% reduction in the optical density at 492 nm compared with those for the control were taken as endpoints for the calculation of synergy, and a good correlation between both estimates was demonstrated.

Full Text

The Full Text of this article is available as a PDF (176.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berenbaum M. C. Synergy, additivism and antagonism in immunosuppression. A critical review. Clin Exp Immunol. 1977 Apr;28(1):1–18. [PMC free article] [PubMed] [Google Scholar]
  2. Dermoumi H. In vitro susceptibility of fungal isolates of clinically important specimens to itraconazole, fluconazole and amphotericin B. Chemotherapy. 1994 Mar-Apr;40(2):92–98. doi: 10.1159/000239178. [DOI] [PubMed] [Google Scholar]
  3. Domenico P., Hopkins T., Schoch P. E., Cunha B. A. Potentiation of aminoglycoside inhibition and reduction of capsular polysaccharide production in Klebsiella pneumoniae by sodium salicylate. J Antimicrob Chemother. 1990 Jun;25(6):903–914. doi: 10.1093/jac/25.6.903. [DOI] [PubMed] [Google Scholar]
  4. Freese E., Sheu C. W., Galliers E. Function of lipophilic acids as antimicrobial food additives. Nature. 1973 Feb 2;241(5388):321–325. doi: 10.1038/241321a0. [DOI] [PubMed] [Google Scholar]
  5. Odds F. C. Resistance of yeasts to azole-derivative antifungals. J Antimicrob Chemother. 1993 Apr;31(4):463–471. doi: 10.1093/jac/31.4.463. [DOI] [PubMed] [Google Scholar]
  6. Pfaller M. A., Grant C., Morthland V., Rhine-Chalberg J. Comparative evaluation of alternative methods for broth dilution susceptibility testing of fluconazole against Candida albicans. J Clin Microbiol. 1994 Feb;32(2):506–509. doi: 10.1128/jcm.32.2.506-509.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Polak A. Combination therapy in systemic mycosis. J Chemother. 1990 Aug;2(4):211–217. doi: 10.1080/1120009x.1990.11739020. [DOI] [PubMed] [Google Scholar]
  8. Price M. F., LaRocco M. T., Gentry L. O. Fluconazole susceptibilities of Candida species and distribution of species recovered from blood cultures over a 5-year period. Antimicrob Agents Chemother. 1994 Jun;38(6):1422–1424. doi: 10.1128/aac.38.6.1422. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Tariq V. N., Scott E. M., McCain N. E. Use of decimal assay for additivity to demonstrate synergy in pair combinations of econazole, nikkomycin Z, and ibuprofen against Candida albicans in vitro. Antimicrob Agents Chemother. 1995 Dec;39(12):2615–2619. doi: 10.1128/aac.39.12.2615. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Vazquez J. A., Sanchez V., Dmuchowski C., Dembry L. M., Sobel J. D., Zervos M. J. Nosocomial acquisition of Candida albicans: an epidemiologic study. J Infect Dis. 1993 Jul;168(1):195–201. doi: 10.1093/infdis/168.1.195. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES